3 rising biotech stars

Financial journalist and commentator on 3AW and Sky Business
Print This Post A A A

Australia’s biotech reputation – in both potential drugs and in diagnostic devices – is deservedly high. Here are three of my favourite potential biotech stars on the ASX.

LBT Innovations (LBT, 14 cents)

Market capitalisation: $21 million

Take a free trial to continue reading

Already have an account? Login to continue reading.

By proceeding you understand and agree to the site's terms and conditions

Also from this edition